Arrowhead Pharmaceuticals
ARWR
#1823
Rank
S$15.27 B
Marketcap
S$108.46
Share price
4.41%
Change (1 day)
407.03%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): S$0.46 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are S$1.09 Billion. , an increase over its 2024 earnings that were of -S$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 S$0.44 B-157.5%
2024 -S$0.78 Billion112.45%
2023 -S$0.37 Billion87.79%
2022 -S$0.2 Billion-20.1%
2021 -S$0.25 Billion67.59%
2020 -S$0.15 Billion-347.53%
2019 S$58.61 M-245.59%
2018 -S$40.26 Million-13.17%
2017 -S$46.37 Million-52.28%
2016 -S$97.18 Million-16.57%
2015 -S$0.12 Billion30.32%
2014 -S$89.38 Million171.62%
2013 -S$32.91 Million16.56%
2012 -S$28.23 Million107.53%
2011 -S$13.61 Million
2008 -S$47.92 Million-8.07%
2007 -S$52.12 Million70.37%
2006 -S$30.6 Million122.51%
2005 -S$13.75 Million147.41%
2004 -S$5.56 Million2002.28%
2003 -S$0.27 Million-85.61%
2002 -S$1.84 Million1371.97%
2001 -S$0.13 Million-13.45%
2000 -S$0.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.54 B 7,427.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-S$4.02 Billion-1,001.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.21 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion-134.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.12 B 151.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-S$0.14 Billion-131.32%๐Ÿ‡บ๐Ÿ‡ธ USA